Figure 1B shows the natural abundance of HDO in the mouse brain before injection of [6,6]- 2 H 2 glucose, which was used as an internal concentration reference
"Rather than viewing regain as a setback, I encourage patients to see it as feedback," he says
But if you experience fatigue, hair loss, dizziness, or prolonged reduced intake, testing can help identify correctable deficiencies
She cautioned, however, that patients taking weight loss peptides must stay well hydrated and consume enough protein, since the drugs can suppress appetite to the point where adequate nutrition becomes difficult
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
